Insmed (INSM) Free Cash Flow (2010 - 2026)

Insmed's Free Cash Flow history runs 17 years deep, the most recent figure standing at -$226.2 million for Q1 2026.

• On a quarterly basis, Free Cash Flow rose 16.88% year-over-year to -$226.2 million in Q1 2026; TTM through Mar 2026 was -$891.2 million, a 16.65% decrease from a year earlier, with the FY2025 full-year figure at -$937.1 million, down 38.72% from the prior year.
• Free Cash Flow grew to -$226.2 million in Q1 2026 per INSM's latest filing, from -$259.4 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$98.2 million in Q3 2022 and bottomed at -$272.2 million in Q1 2025.
• The 5-year median for Free Cash Flow is -$149.7 million (2023), against an average of -$164.6 million.
• Across the five-year window, Free Cash Flow gained 27.8% in 2022 and plunged 94.31% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at -$100.0 million in 2022, then sank by 32.97% to -$133.0 million in 2023, then tumbled by 45.35% to -$193.3 million in 2024, then plunged by 34.21% to -$259.4 million in 2025, then advanced by 12.79% to -$226.2 million in 2026.
• Per Business Quant, the three latest INSM Free Cash Flow figures stand at -$226.2 million (Q1 2026), -$259.4 million (Q4 2025), and -$196.5 million (Q3 2025).